Illumina Files Suit Seeking Payments from Shuttered DNAPrint | GenomeWeb

NEW YORK (GenomeWeb News) – Illumina has filed a lawsuit against DNAPrint Genomics and its Ellipsis Biotherapeutics subsidiary seeking payment for products Illumina shipped to the firm in 2007-2008.

According to the suit, which was filed last week in the US District Court for the Southern District of California, Illumina is seeking nearly $275,000 in payments from DNAPrint Genomics for genotyping kits and DNA analysis kits that it ordered from Illumina and didn't pay for, as stipulated under a contract between the firms in April 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.